Clinical trials recruiting for Metastatic Colorectal Carcinoma (mCRC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Olanzapine | 1 |
| Tegavivint | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| Oregon | 1 |
Top cities
Self-screener
Recruiting trials
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
- Streamlining Radioembolization for CCC and Metastatic Liver Cancer
Related conditions
Trials recruiting for Metastatic Colorectal Carcinoma (mCRC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Colorectal Carcinoma (mCRC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.